Adaptin Bio (APTN) Other financing activities (2025)
Adaptin Bio's (APTN) quarterly Other financing activities came in at $999999.0 in Q4 2025, down 83.77% quarter-over-quarter from $6.2 million in Q1 2025.
Powered by 
Analysis
Adaptin Bio (APTN) Other financing activities (2025) Analysis & Trends
Adaptin Bio has disclosed Other financing activities across 1 years of filings, most recently posting $999999.0 for Q4 2025.
- In Q4 2025, Other financing activities changed N/A year-over-year to $999999.0; the TTM figure through Dec 2025 stood at $7.2 million (changed N/A YoY), while the FY2025 annual figure was $7.2 million, changed N/A from the prior year.
- Other financing activities came in at $999999.0 for Q4 2025 at Adaptin Bio, down from $6.2 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $6.2 million in Q1 2025 to a low of $999999.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Adaptin Bio | 56.76 Mn | 56.09 Mn | - |